Update: 07.11.2022
Last week: 43 week 2022 (24.10.2022 - 30.10.2022)
Last full month: September 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 137 164 | 0.9% | 3.7% | 0.1 | 29 905 798 | 1.4% | 3.9% | 0.1 | -0.8% |
| MoM | 747 528 | 79.1% | 3.7% | 0 | 153 590 034 | 85.1% | 3.8% | 0.1 | 81.0% |
| YTD | 8 320 038 | -19.5% | 5.3% | -1.1 | 1 660 226 572 | -5.5% | 5.1% | -0.7 | -2.7% |
| MAT | 11 254 356 | -4.5% | 5.5% | -0.1 | 2 193 859 840 | 10.1% | 5.3% | 0.2 | -2.7% |
| DEXALGIN | |||||||||
| WoW | 17 632 | -1.4% | 0.4% | 0 | 8 889 710 | -1.8% | 1.3% | 0 | -2.9% |
| MoM | 90 811 | 16.9% | 0.4% | 0 | 43 312 453 | 19.6% | 1.1% | 0 | 21.7% |
| YTD | 1 425 644 | 1.1% | 0.7% | 0 | 607 975 780 | 13.4% | 1.8% | 0 | 0.4% |
| MAT | 1 853 840 | 6.1% | 0.7% | 0 | 772 826 819 | 16.9% | 1.9% | 0.1 | -0.9% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 51 610 | -0.9% | 43.2% | 0 | 27 099 376 | -1.4% | 49.9% | 0 | -1.0% |
| MoM | 281 557 | 10.8% | 46.3% | -0.4 | 148 737 462 | 10.9% | 52.0% | -0.6 | 11.7% |
| YTD | 3 787 604 | -11.9% | 55.2% | -11.3 | 1 928 220 481 | -1.5% | 60.7% | -9.9 | 6.2% |
| MAT | 4 768 913 | -7.6% | 56.7% | -9.4 | 2 394 800 067 | 3.2% | 62.2% | -8.1 | 7.7% |
| ESPUMISAN BABY | |||||||||
| WoW | 20 802 | -4.7% | 31.5% | -0.5 | 13 494 622 | -5.0% | 45.0% | -0.2 | -3.2% |
| MoM | 112 687 | 10.3% | 34.9% | -0.1 | 73 791 527 | 12.4% | 48.2% | 0.5 | 10.7% |
| YTD | 1 215 833 | -12.3% | 37.8% | -3.9 | 760 126 650 | -5.9% | 51.0% | -5.5 | -3.2% |
| MAT | 1 492 687 | -13.2% | 38.1% | -3.7 | 923 998 890 | -6.3% | 51.6% | -4.6 | -4.9% |
| FASTUM | |||||||||
| WoW | 13 967 | 1.6% | 0.8% | 0 | 7 863 757 | 0.7% | 2.2% | 0.1 | -4.3% |
| MoM | 77 456 | 19.6% | 0.9% | 0 | 42 173 280 | 18.5% | 2.2% | 0.1 | 15.2% |
| YTD | 897 017 | -23.1% | 1.1% | -0.3 | 464 706 373 | -13.3% | 2.5% | -0.6 | 0.3% |
| MAT | 1 115 208 | -22.5% | 1.2% | -0.3 | 568 597 844 | -13.2% | 2.6% | -0.6 | -0.5% |
| IODOMARIN | |||||||||
| WoW | 73 916 | 3.3% | 23.8% | 0.7 | 13 661 249 | 2.3% | 10.4% | 0.7 | 0.1% |
| MoM | 335 689 | 32.6% | 24.3% | 2.3 | 62 171 772 | 28.4% | 10.7% | 1 | 20.3% |
| YTD | 2 684 005 | 6.3% | 20.2% | 0 | 527 571 225 | 11.2% | 9.1% | -0.1 | 6.1% |
| MAT | 3 325 108 | 18.1% | 20.6% | 2 | 645 746 365 | 20.4% | 9.3% | 0.8 | 6.5% |
| LIOTON | |||||||||
| WoW | 14 510 | 0.4% | 1.6% | 0.1 | 16 651 745 | 3.3% | 3.9% | 0.3 | -3.4% |
| MoM | 83 625 | -9.1% | 1.8% | -0.2 | 90 280 193 | -8.4% | 3.9% | -0.4 | 1.3% |
| YTD | 1 108 028 | -23.7% | 2.3% | -0.5 | 1 139 606 721 | -4.3% | 4.7% | -0.9 | -7.0% |
| MAT | 1 348 221 | -20.9% | 2.3% | -0.4 | 1 351 688 166 | -2.2% | 4.8% | -0.7 | -7.2% |
| MEZYM | |||||||||
| WoW | 196 037 | -2.8% | 18.7% | -0.2 | 29 494 348 | -3.8% | 13.5% | -0.2 | -1.7% |
| MoM | 1 012 478 | 8.5% | 18.9% | -0.8 | 154 387 022 | 9.1% | 13.4% | -0.5 | 13.2% |
| YTD | 15 308 746 | -7.3% | 26.7% | -1.7 | 2 341 363 032 | 1.4% | 19.1% | -2.1 | -1.3% |
| MAT | 19 558 902 | -2.3% | 27.7% | -0.6 | 2 940 012 604 | 5.1% | 19.9% | -1.3 | -0.3% |
| MIG 400 | |||||||||
| WoW | 123 196 | -2.0% | 2.8% | 0 | 14 877 759 | -2.0% | 2.2% | 0 | -2.9% |
| MoM | 705 306 | 16.2% | 2.8% | -0.1 | 83 916 288 | 16.1% | 2.2% | 0 | 21.7% |
| YTD | 7 160 468 | -13.0% | 3.3% | -0.5 | 843 735 346 | -9.0% | 2.5% | -0.6 | 0.4% |
| MAT | 8 820 109 | -9.6% | 3.4% | -0.3 | 1 033 637 348 | -5.8% | 2.6% | -0.4 | -0.9% |
| PROSTAMOL | |||||||||
| WoW | 20 226 | -6.7% | 13.9% | -1 | 27 687 285 | -7.8% | 14.5% | -1.2 | -0.2% |
| MoM | 107 142 | 27.2% | 15.1% | 0 | 149 162 441 | 25.9% | 16.1% | 0.2 | 27.1% |
| YTD | 1 336 087 | -25.0% | 19.1% | -6 | 1 871 850 746 | -16.3% | 20.4% | -7 | -1.5% |
| MAT | 1 693 735 | -21.3% | 19.7% | -4.8 | 2 335 979 245 | -13.0% | 21.0% | -5.7 | -2.0% |
| RESPERO MYRTOL | |||||||||
| WoW | 19 548 | 2.4% | 6.7% | 0 | 9 648 149 | 3.2% | 7.1% | 0 | 3.1% |
| MoM | 111 511 | 68.8% | 7.7% | -1.4 | 53 402 083 | 71.8% | 8.0% | -1.2 | 99.0% |
| YTD | 1 028 025 | 107.2% | 8.7% | 4.5 | 482 859 443 | 106.9% | 8.6% | 4 | 1.2% |
| MAT | 1 278 670 | 109.4% | 8.6% | 4.4 | 594 406 044 | 106.0% | 8.5% | 3.8 | 2.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 8 320 038 | -19.5% | 5.3% | -1.1 | 1 660 226 572 | -5.5% | 5.1% | -0.7 | -2.7% |
| DEXALGIN | 1 425 644 | 1.1% | 0.7% | 0 | 607 975 780 | 13.4% | 1.8% | 0 | 0.4% |
| ESPUMISAN (ADULTS) | 3 787 604 | -11.9% | 55.2% | -11.3 | 1 928 220 481 | -1.5% | 60.7% | -9.9 | 6.2% |
| ESPUMISAN BABY | 1 215 833 | -12.3% | 37.8% | -3.9 | 760 126 650 | -5.9% | 51.0% | -5.5 | -3.2% |
| FASTUM | 897 017 | -23.1% | 1.1% | -0.3 | 464 706 373 | -13.3% | 2.5% | -0.6 | 0.3% |
| IODOMARIN | 2 684 005 | 6.3% | 20.2% | 0 | 527 571 225 | 11.2% | 9.1% | -0.1 | 6.1% |
| LIOTON | 1 108 028 | -23.7% | 2.3% | -0.5 | 1 139 606 721 | -4.3% | 4.7% | -0.9 | -7.0% |
| MEZYM | 15 308 746 | -7.3% | 26.7% | -1.7 | 2 341 363 032 | 1.4% | 19.1% | -2.1 | -1.3% |
| MIG 400 | 7 160 468 | -13.0% | 3.3% | -0.5 | 843 735 346 | -9.0% | 2.5% | -0.6 | 0.4% |
| PROSTAMOL | 1 336 087 | -25.0% | 19.1% | -6 | 1 871 850 746 | -16.3% | 20.4% | -7 | -1.5% |
| RESPERO MYRTOL | 1 028 025 | 107.2% | 8.7% | 4.5 | 482 859 443 | 106.9% | 8.6% | 4 | 1.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 11 254 356 | -4.5% | 5.5% | -0.1 | 2 193 859 840 | 10.1% | 5.3% | 0.2 | -2.7% |
| DEXALGIN | 1 853 840 | 6.1% | 0.7% | 0 | 772 826 819 | 16.9% | 1.9% | 0.1 | -0.9% |
| ESPUMISAN (ADULTS) | 4 768 913 | -7.6% | 56.7% | -9.4 | 2 394 800 067 | 3.2% | 62.2% | -8.1 | 7.7% |
| ESPUMISAN BABY | 1 492 687 | -13.2% | 38.1% | -3.7 | 923 998 890 | -6.3% | 51.6% | -4.6 | -4.9% |
| FASTUM | 1 115 208 | -22.5% | 1.2% | -0.3 | 568 597 844 | -13.2% | 2.6% | -0.6 | -0.5% |
| IODOMARIN | 3 325 108 | 18.1% | 20.6% | 2 | 645 746 365 | 20.4% | 9.3% | 0.8 | 6.5% |
| LIOTON | 1 348 221 | -20.9% | 2.3% | -0.4 | 1 351 688 166 | -2.2% | 4.8% | -0.7 | -7.2% |
| MEZYM | 19 558 902 | -2.3% | 27.7% | -0.6 | 2 940 012 604 | 5.1% | 19.9% | -1.3 | -0.3% |
| MIG 400 | 8 820 109 | -9.6% | 3.4% | -0.3 | 1 033 637 348 | -5.8% | 2.6% | -0.4 | -0.9% |
| PROSTAMOL | 1 693 735 | -21.3% | 19.7% | -4.8 | 2 335 979 245 | -13.0% | 21.0% | -5.7 | -2.0% |
| RESPERO MYRTOL | 1 278 670 | 109.4% | 8.6% | 4.4 | 594 406 044 | 106.0% | 8.5% | 3.8 | 2.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 137 164 | 0.9% | 3.7% | 0.1 | 29 905 798 | 1.4% | 3.9% | 0.1 | -0.8% |
| DEXALGIN | 17 632 | -1.4% | 0.4% | 0 | 8 889 710 | -1.8% | 1.3% | 0 | -2.9% |
| ESPUMISAN (ADULTS) | 51 610 | -0.9% | 43.2% | 0 | 27 099 376 | -1.4% | 49.9% | 0 | -1.0% |
| ESPUMISAN BABY | 20 802 | -4.7% | 31.5% | -0.5 | 13 494 622 | -5.0% | 45.0% | -0.2 | -3.2% |
| FASTUM | 13 967 | 1.6% | 0.8% | 0 | 7 863 757 | 0.7% | 2.2% | 0.1 | -4.3% |
| IODOMARIN | 73 916 | 3.3% | 23.8% | 0.7 | 13 661 249 | 2.3% | 10.4% | 0.7 | 0.1% |
| LIOTON | 14 510 | 0.4% | 1.6% | 0.1 | 16 651 745 | 3.3% | 3.9% | 0.3 | -3.4% |
| MEZYM | 196 037 | -2.8% | 18.7% | -0.2 | 29 494 348 | -3.8% | 13.5% | -0.2 | -1.7% |
| MIG 400 | 123 196 | -2.0% | 2.8% | 0 | 14 877 759 | -2.0% | 2.2% | 0 | -2.9% |
| PROSTAMOL | 20 226 | -6.7% | 13.9% | -1 | 27 687 285 | -7.8% | 14.5% | -1.2 | -0.2% |
| RESPERO MYRTOL | 19 548 | 2.4% | 6.7% | 0 | 9 648 149 | 3.2% | 7.1% | 0 | 3.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 747 528 | 79.1% | 3.7% | 0 | 153 590 034 | 85.1% | 3.8% | 0.1 | 81.0% |
| DEXALGIN | 90 811 | 16.9% | 0.4% | 0 | 43 312 453 | 19.6% | 1.1% | 0 | 21.7% |
| ESPUMISAN (ADULTS) | 281 557 | 10.8% | 46.3% | -0.4 | 148 737 462 | 10.9% | 52.0% | -0.6 | 11.7% |
| ESPUMISAN BABY | 112 687 | 10.3% | 34.9% | -0.1 | 73 791 527 | 12.4% | 48.2% | 0.5 | 10.7% |
| FASTUM | 77 456 | 19.6% | 0.9% | 0 | 42 173 280 | 18.5% | 2.2% | 0.1 | 15.2% |
| IODOMARIN | 335 689 | 32.6% | 24.3% | 2.3 | 62 171 772 | 28.4% | 10.7% | 1 | 20.3% |
| LIOTON | 83 625 | -9.1% | 1.8% | -0.2 | 90 280 193 | -8.4% | 3.9% | -0.4 | 1.3% |
| MEZYM | 1 012 478 | 8.5% | 18.9% | -0.8 | 154 387 022 | 9.1% | 13.4% | -0.5 | 13.2% |
| MIG 400 | 705 306 | 16.2% | 2.8% | -0.1 | 83 916 288 | 16.1% | 2.2% | 0 | 21.7% |
| PROSTAMOL | 107 142 | 27.2% | 15.1% | 0 | 149 162 441 | 25.9% | 16.1% | 0.2 | 27.1% |
| RESPERO MYRTOL | 111 511 | 68.8% | 7.7% | -1.4 | 53 402 083 | 71.8% | 8.0% | -1.2 | 99.0% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs